Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres

References

• Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–1403.
   PubMed Web of Science ®Google Scholar
• The National Board of Health and Welfare Official stastistics of Sweden. Statistics on cancer incidence 2016 in Sweden 2017,December 31. Available from: https://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/20787/2017-12-31.pdf.
   Google Scholar
• Draisma G, Boer R, Otto SJ, et al. Lead times and over detection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst. 2003;95(12):868–878.
   PubMed Web of Science ®Google Scholar
• Sanchez-Chapado M, Olmedilla G, Cabeza M, et al. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study. Prostate. 2003;54(3):238–247.
   PubMed Web of Science ®Google Scholar
• Soos G, Tsakiris I, Szanto J, et al. The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study. Eur Urol. 2005;48(5):739–744.
   PubMed Web of Science ®Google Scholar
• Telesca D, Etzioni R, Gulati R. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends. Biometrics. 2008;64(1):10.
   PubMed Web of Science ®Google Scholar
• Loeb S, Bjurlin MA, Nicholson J, et al. Overdiagnosis and Overtreatment of Prostate Cancer [Review]. Eur Urol. 2014;65(6):1046–1055.
   PubMed Web of Science ®Google Scholar
• Vårdprogramgruppen för prostatacancer Regionala cancercentrum i samverkan. Nationellt vårdprogram prostatacancer 2018, December 11 [2019-03-08]. Available from: https://www.cancercentrum.se/samverkan/cancerdiagnoser/prostata/vardprogram/gallande-vardprogram-prostatacancer/.
   Google Scholar
• Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815–822.
   PubMed Web of Science ®Google Scholar
• Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018;378(19):1767–1777.
   PubMed Web of Science ®Google Scholar
• Sonn GA, Fan RE, Ghanouni P, et al. Prostate magnetic resonance imaging interpretation varies substantially across radiologists. Eur Urol Focus. 2017;5(4):592–599.
   PubMedGoogle Scholar
• Futterer JJ, Briganti A, De Visschere P, et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol. 2015;68(6):1045–1053.
   PubMed Web of Science ®Google Scholar
• Moldovan PC, Van den Broeck T, Sylvester R, et al. What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel. Eur Urol. 2017;72(2):250–266.
   PubMed Web of Science ®Google Scholar
• Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71(4):618–629.
   PubMed Web of Science ®Google Scholar
• Mottet N, Briers E, Cornford P, et al. EAU – EANM – ESTRO – ESUR – SIOG guidelines on prostate cancer: EAU guidelines office, Arnhem, The Netherlands; 2019 [cited 28 June 2019]. Available from: https://uroweb.org/guideline/prostate-cancer/.
   Google Scholar
• Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS prostate imaging – reporting and data system: 2015, Version 2. Eur Urol. 2016;69(1):16–40.
   PubMed Web of Science ®Google Scholar
• Mertan FV, Greer MD, Shih JH, et al. Prospective evaluation of the prostate imaging reporting and data system version 2 for prostate cancer detection. J Urol. 2016;196(3):690–696.
   PubMed Web of Science ®Google Scholar
• Seo JW, Shin SJ, Taik Oh Y, et al. PI-RADS version 2: Detection of clinically significant cancer in patients with biopsy gleason score 6 prostate cancer. AJR Am J Roentgenol. 2017;209(1):W1–W9.
   PubMed Web of Science ®Google Scholar
• Rosenkrantz AB, Ginocchio LA, Cornfeld D, et al. Interobserver reproducibility of the PI-RADS version 2 Lexicon: A multicenter study of six experienced prostate radiologists. Radiology. 2016;280(3):793–804.
   PubMed Web of Science ®Google Scholar
• Kasel-Seibert M, Lehmann T, Aschenbach R, et al. Assessment of PI-RADS v2 for the detection of prostate cancer. European Journal of Radiology. 2016;85(4):726–731.
   PubMed Web of Science ®Google Scholar
• Muller BG, Shih JH, Sankineni S, et al. Prostate cancer: Interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR imaging. Radiology. 2015;277(3):741–750.
   PubMed Web of Science ®Google Scholar
• Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement. 1960;20(1):37–46.
   Web of Science ®Google Scholar
• Greer MD, Brown AM, Shih JH, et al. Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study. J Magn Reson Imaging. 2017;45(2):579–585.
   PubMed Web of Science ®Google Scholar
• de Rooij M, Hamoen EH, Futterer JJ, et al. Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. AJR Am J Roentgenol. 2014;202(2):343–351.
   PubMed Web of Science ®Google Scholar
• Borofsky S, George AK, Gaur S, et al. What are we missing? False-negative cancers at multiparametric MR imaging of the prostate. Radiology. 2018;286(1):186–195.
   PubMed Web of Science ®Google Scholar
• Rosenkrantz AB, Ayoola A, Hoffman D, et al. The learning curve in prostate MRI interpretation: self-directed learning versus continual reader feedback. AJR Am J Roentgenol. 2017;208(3):W92–W100.
   PubMed Web of Science ®Google Scholar
• Niu XK, Chen XH, Chen ZF, et al. Diagnostic performance of biparametric MRI for detection of prostate cancer: a systematic review and meta-analysis. AJR Am J Roentgenol. 2018;211(2):369–378.
   PubMed Web of Science ®Google Scholar
• Kang Z, Min X, Weinreb J, et al. Abbreviated biparametric versus standard multiparametric MRI for diagnosis of prostate cancer: a systematic review and meta-analysis. AJR Am J Roentgenol. 2018;4:W1–W9.
   Google Scholar